Evidence map›Paper›PMID 30641954›Full record

ArticleMarine drugs2019

Structure Analysis and Anti-Tumor and Anti-Angiogenic Activities of Sulfated Galactofucan Extracted from

Weihua Jin, Wanli Wu, Hong Tang, Bin Wei, Hong Wang, Jiadong Sun, Wenjing Zhang, Weihong Zhong

Abstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Marine drugs · 2020
    Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Weihua JinCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China. jinweihua@zjut.edu.cn.ORCID 0000-0002-0551-0291
Wanli WuCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China. 15726816712@163.com.
Hong TangCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China. 17816035715@163.com.
Bin WeiCollaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals & College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China. binwei@zjut.edu.cn.ORCID 0000-0001-7362-1228
Hong WangCollaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals & College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China. hongw@zjut.edu.cn.ORCID 0000-0003-0058-060X
Jiadong SunDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA. jiadong.sun@nih.gov.
Wenjing ZhangCollege of Life and Environmental Science, Wenzhou University, Wenzhou 325035, China. wenjingzhang09@foxmail.com.
Weihong ZhongCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China. whzhong@zjut.edu.cn.

Funding

National Natural Science Foundation of China 41506165the National Key Research and Development Program of China 2017YFE0103100the Open Fund of Key Laboratory of Experimental Marine Biology, Chinese Academy of Sciences KF2018NO2Zhejiang Provincial Natural Science Foundation of China LY19D060006
6 · The paper itself

Abstract

Sulfated galactofucan (ST-2) was obtained from

Indexed as

A549 CellsAngiogenesis InhibitorsAntineoplastic AgentsDrug Evaluation, PreclinicalGalactoseHumansHuman Umbilical Vein Endothelial CellsMagnetic Resonance SpectroscopyMolecular StructureMolecular WeightPolysaccharidesSargassumAngiogenesis InhibitorsAntineoplastic AgentsfucoidanGalactosePolysaccharidesanti-angiogenic activityanti-tumor activityfucoidanSargassum thunbergiisulfated galactofucan

Identifiers

PMID30641954
PMCPMC6356460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.